Federal and Regulatory Outreach
AMRPA & NALTH Send Joint Letter to CMS on Medicare Advantage Prior Authorization
December 9, 2020
Medicare Advantage Prior Authorization Regulatory
AMRPA Submits Comment to CMS on CY 2022 Medicare Advantage and Part D Advance Notice Parts I and II
November 30, 2020
Medicare Advantage Prior Authorization Regulatory
AMRPA Submits Comments to CMS on Medicare Care Compare Site
November 12, 2020
COVID-19 Price Transparency
AMRPA Submits Comments on CY 2021 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule
October 6, 2020
Physician Fee Schedule Regulatory Telehealth
AMRPA Letter to Congressional Leadership Regarding IMPACT Act’s Timeline & Prototype Testing
July 30, 2020
IMPACT Act IRF QRP Legislative Quality
AMRPA’s Response to the CMS Proposed Rule on Inpatient Prospective Payment System for FY 2021
July 10, 2020
IPPS/LTCH PPS Price Transparency Regulatory
AMRPA’s Submissions to the CMS Interim Final Rule on COVID-19
July 9, 2020
Burden Reduction COVID-19 Price Transparency Prior Authorization Regulatory Telehealth
AMRPA Recommendations to Senate HELP Committee Regarding Pandemic Preparedness Legislation
June 26, 2020
COVID-19 Legislative Prior Authorization Telehealth
AMRPA Submits Comments on Fiscal Year 2021 Inpatient Rehabilitation Facility Prospective Payment System Proposed Rule
June 5, 2020
Burden Reduction IRF PPS IRF QRP Regulatory
AMRPA Response to Medicare Advantage Part C Proposed Rule for FY 2021 and 2022
April 6, 2020
Medicare Advantage Prior Authorization
Letter to HHS & CMS Administrators Regarding COVID-19
March 13, 2020
COVID-19
AMRPA Statement on Proposed CMS IRF Choice Review Demonstration